Skip to main content

Opioids in Chronic Pain

  • Chapter
Chronic Pain

Part of the book series: Current Clinical Practice ((CCP))

  • 1019 Accesses

Abstract

Mr. Walter is a 55-year-old man with chronic low back pain. He underwent three back surgeries—including a fusion procedure, epidural steroid injections, facet blocks, and numerous medication trials—without benefit. He is a chef and restaurant owner, but his pain has prevented him from cooking in the restaurant or spending more than about 2 hours a day at work. He had been treated with nonsteroidal analgesics, but developed anemia from gastric ulcers. A trial of tramadol was unsuccessful. Mr. Walter’s examination revealed pain with postural changes and restricted motion in his lumbar spine. He had no leg weakness, reflex changes, or numbness. His doctor diagnosed mechanical back pain and, after ensuring no history of drug or alcohol abuse, treated him with short-acting hydrocodone. Mr. Walter was instructed to take hydrocodone only when his pain was debilitating, and was given 30 pills. Mr. Walter called the clinic after 1 week, reporting good results from the hydrocodone, with mild constipation controlled by adding prune juice to breakfast and no cognitive effects. He requested a medication refill. The partner of Mr. Walter’s treating physician authorized four refills. Mr. Walter returned to the clinic in 1 month and reported great satisfaction with his medication. He reported he could now grade his pain with a score of 6, on a scale of 1–10, instead of 9, and that he was sleeping better at night because his pain diminished and was able to spend 6 hours a day at the restaurant. He had even restarted cooking for some meals. In addition, he had resumed his stretching and flexion exercise program, now that his pain was better controlled. Although encouraged by this good report, Mr. Walter’s doctor was surprised to see that in 1 month, Mr. Walter had used 150 tablets. The doctor angrily asked why Mr. Walter was using the medication so frequently, reminding Mr. Walter that he was instructed to use hydrocodone only for severe pain. Mr. Walter replied that his pain was always severe, and hydrocodone effectively relieved his pain, but only for approximately 4 hours. Therefore, Mr. Walter was taking hydrocodone four times daily. The doctor discontinued hydrocodone and requested consultation at a drug abuse facility.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Friedman DP. Perspectives on the medical use of drugs of abuse. J Pain Symptom Manage 1990; 5(Suppl):S2–S5.

    PubMed  CAS  Google Scholar 

  2. Shannon CN, Baranowski AP. Use of opioids in non-cancer pain. Br J Hosp Med 1997; 5:459–463.

    Google Scholar 

  3. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am 1999; 83:761–786.

    Article  PubMed  CAS  Google Scholar 

  4. Mantyselka P, Ahonen R, Kumpusalo E, Takala J. Variability in prescribing for musculoskeletal pain in Finnish primary health care. Pharm World Sci 2001; 23:232–236.

    Article  PubMed  CAS  Google Scholar 

  5. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 2002; 23:131–137.

    Article  PubMed  Google Scholar 

  6. Eriksen J, Jensen MK, Sjøgren P, Ekholm O, Rasmussen NK. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003; 106:221–228.

    Article  PubMed  Google Scholar 

  7. Kromann-Andersen H, Pedersen A. Reported adverse reactions to and consumption of nonsteroidal anti-inflammatory drugs in Denmark over a 17-year period. Dan Med Bull 1988; 35:187–192.

    PubMed  CAS  Google Scholar 

  8. Matzke GR. Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents. An J Kidney Dis 1996; 28 (1 Suppl 1):S63–S70.

    Google Scholar 

  9. McGoldrick MD, Bailie GR. Nonnarcotic analgesics: prevalence and estimated economic impact of toxicities. Ann Pharmacother 1997; 31:221–227.

    PubMed  CAS  Google Scholar 

  10. Lapane KL, Spooner JJ, Pettitt D. The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis. Am J Manag Care 2001; 7:402–408.

    PubMed  CAS  Google Scholar 

  11. Simon LS, Weaver AL, Graham DY, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. A randomized controlled trial. JAMA 1999; 282:1921–1928.

    Article  PubMed  CAS  Google Scholar 

  12. Segasothy M, Chin GL, Sia KK, et al. Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis. Br J Rheumatol 1995; 34:162–165.

    Article  PubMed  CAS  Google Scholar 

  13. Segasothy M, Samad SA, Zulfigar A, Bennett WM. Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 1994; 24:17–24.

    PubMed  CAS  Google Scholar 

  14. LeLorier J, Bombardier C, Burgess E, et al. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease. Can J Cardiol 2002; 18:1301–1308.

    PubMed  CAS  Google Scholar 

  15. Deider J, Stampfer MJ, Hankison SE, Willett WC, Speizer FE, Curhan GC. Non-narcotic analgesic use and risk of hypertension in US women. Hypertension 2002; 40:604–608.

    Article  Google Scholar 

  16. Heerdink ER, Leufkens HG, Herings RM, et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Int Med 1998; 158:1108–1112.

    Article  CAS  Google Scholar 

  17. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain: a randomized prospective study. Spine 1998; 23:2591–2600.

    Article  PubMed  CAS  Google Scholar 

  18. Roth SH, Fleischman RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain. Placebo-controlled trial and long-term evaluation. Arch Intern Med 2000; 160:853–860.

    Article  PubMed  CAS  Google Scholar 

  19. Schofferman J. Long-term opioid analgesic therapy for refractory lumbar spine pain. Clin J Pain 1999; 15:136–140.

    Article  PubMed  CAS  Google Scholar 

  20. Eckhardt K, Ammon S, Hofmann U, et al. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 2000; 91:185–191.

    Article  PubMed  CAS  Google Scholar 

  21. Staats PS, Markowitz J, Schein J. Incidence of constipation associated with long-acting opioid therapy: a comparative study. South Med J 2004; 97:129–134.

    Article  PubMed  Google Scholar 

  22. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O’Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002; 17:173–179.

    Article  PubMed  Google Scholar 

  23. Chabal C, Erjavec MK, Jacobson L, et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain 1997; 13:150–155.

    Article  PubMed  CAS  Google Scholar 

  24. Ossipov MH, Lai J, Vanderah TW, Porreca F. Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci 2003; 73:783–800.

    Article  PubMed  CAS  Google Scholar 

Download references

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

(2005). Opioids in Chronic Pain. In: Marcus, D.A. (eds) Chronic Pain. Current Clinical Practice. Humana Press. https://doi.org/10.1385/1-59259-882-X:269

Download citation

  • DOI: https://doi.org/10.1385/1-59259-882-X:269

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-501-9

  • Online ISBN: 978-1-59259-882-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics